Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The peptide's short half-life necessitates daily administration for consistent therapeutic effects
It exists in both injectable and capsule (oral) forms in experimental or underground usage
Important Notes These are the points most often dropped when AHK-Cu is marketed as an injectable hair-growth peptide. No human trial exists state it plainly: there is no clinical trial of AHK-Cu by any route, and the entire peptide-specific peer-reviewed base is one 2007 study that was ex vivo and in vitro [1]
Some research has shown that even in the absence of functional beta-3 receptors, acute AOD-9604 administration still increased energy expenditure and fat oxidation, suggesting the peptide may influence brown fat or thermogenic pathways through additional mechanisms
Many patients begin noticing changes in energy and appetite regulation within weeks
A beginner's research guide to each peptide, how they compare, and study dosages, with PubMed citations
